CHRIS NARSESIAN: Open Payments
NPI 1073159513 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 57 payments from 13 companies in 2025. Trend: 2023 $229 · 2024 $591 · 2025 $1,229
Food & beverage: $1,034Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $362 |
| ABBVIE INC. | 12 | $229 |
| Amgen Inc. | 9 | $149 |
| GENZYME CORPORATION | 3 | $111 |
| UCB, Inc. | 2 | $65 |
| PFIZER INC. | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Galderma Laboratories, L.P. | 3 | $57 |
| LEO Pharma Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: TREMFYA, SKYRIZI, Otezla, DUPIXENT, Bimzelx, CIBINQO, NEMLUVIO, ANZUPGO.
Industry payments across FL — which companies pay providers there.
